SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-150170
Filing Date
2017-05-01
Accepted
2017-05-01 07:16:04
Documents
5
Period of Report
2017-04-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d386476d8k.htm 8-K 14842
2 EX-99.1 d386476dex991.htm EX-99.1 23844
3 EX-99.2 d386476dex992.htm EX-99.2 12890
4 GRAPHIC g386476stamp10.jpg GRAPHIC 391921
5 GRAPHIC g386476stamp11.jpg GRAPHIC 385384
  Complete submission text file 0001193125-17-150170.txt   1123648
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
RXi Pharmaceuticals Corp (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36304 | Film No.: 17798484
SIC: 2834 Pharmaceutical Preparations